Several studies have shown that expression of costimulatory ligands CD40L, CD70, OX40L, and 4-1BBL on DCs overcomes T-cell tolerance and establishes superior protective immunity to tumor challenge or viral infection. The gene discussed is TNFSF4; the disease is neoplasm.